Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area stem cell stem gsk 3'

Search results for: 'research area stem cell stem gsk 3'

Items 71-80 of 134

Page
per page
  1. Sal 003
    A4541 Sal 003
    Summary: Cellular phosphatase complex inhibitor
      insoluble in H2O; insoluble in EtOH; ≥20.15 mg/mL
  2. 1,2,3,4,5,6-Hexabromocyclohexane
    A4510 1,2,3,4,5,6-Hexabromocyclohexane
    Summary: JAK2 tyrosine kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥8.22 mg/mL
  3. PCI-34051
    A4091 PCI-34051
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC8 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥14.8 mg/mL
  4. Lestaurtinib
    A4513 Lestaurtinib
     1 Citation
    Summary: JAK2/FLT3/TrkA inhibitor
      Soluble in DMSO
  5. CUDC-907
    A4097 CUDC-907
    Target: Histone Deacetylases (HDACs)|PI3K
    Summary: Potent PI3K/HDAC inhibitor
      ≥25.45 mg/mL
  6. R8-T198wt
    A4520 R8-T198wt
    Summary: Pim-1 kinase inhibitor
      Soluble to 2 mg/mL
  7. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  8. AZD1480
    A4137 AZD1480
    Target: JAK
    Summary: JAK2 inhibitor,ATP-competitive and novel
      insoluble in H2O; ≥93.8 mg/mL
  9. Lomeguatrib
    A1912 Lomeguatrib
    Target: O6-methylguanine-DNA-methyl-transferase (MGMT)
    Summary: MGMT inhibitor
      ≥50 mg/mL
  10. Triacetyl Resveratrol
    B5971 Triacetyl Resveratrol
    Summary: Cell-permeable resveratrol prodrug
      insoluble in EtOH; insoluble in H2O; ≥13.85 mg/mL

Items 71-80 of 134

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 6item
  2. Aurora Kinase 15item
  3. DNA Methyltransferase 3item
  4. HDAC 26item
  5. Histone Acetyltransferases 6item
  6. Histone Demethylases 11item
  7. Histone Methyltransferase 9item
  8. HIF 4item
  9. JAK 21item
  10. PARP 9item
  11. Pim 3item
  12. Protein Ser/Thr Phosphatases 11item
  13. RNA Polymerase 3item
  14. Sirtuin 7item
  15. PAD 1 item
Specificity
  1. Selective 40item
Reversibility
  1. Reversible 3item
Target
  1. Histone Deacetylases (HDACs) 17item
  2. PI3K 1 item
  3. Aurora Kinases 13item
  4. EZH2 2item
  5. Bromodomains 1 item
  6. FLT3 3item
  7. PLK 1 item
  8. VEGFR 3item
  9. Hydrolase 1 item
  10. MEK 1 item
  11. DOT1L 1 item
  12. FGFR 2item
  13. Sir2-like Family Deacetylases (Sirtuins) 1 item
  14. PP1 1 item
  15. PP2A 1 item
  16. Src 3item
  17. Trk Receptors 1 item
  18. STAT 2item
  19. EGFR 1 item
  20. JAK 9item
  21. p300 1 item
  22. TNKS 1 item
  23. Topoisomerases 1 item
  24. DNA Methyltransferases 1 item
  25. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  26. PARP 1 item
  27. ALK 1 item
  28. MNK 1 item
  29. AChE 1 item
  30. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  31. PP4 1 item
  32. c-RET 1 item
  33. Protein polybromo-1 1 item
  34. SMARCA4 1 item
  35. SMARCA2 1 item
  36. p53 1 item
  37. HDAC 1 item
  38. TYK2 1 item
  39. MUSK 1 item
  40. MAP3K 1 item
  41. Lck 1 item
  42. p21 1 item
  43. Sirtuin 1 item
Reported Experiments
  1. Animal Experiments 47item
  2. Cell Experiments 39item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 4item
  3. Bladder Cancer 2item
  4. Breast Cancer 12item
  5. Cancer 36item
  6. Cervical Cancer 1 item
  7. Colon Cancer 5item
  8. Colon Carcinoma 1 item
  9. Colorectal Cancer 3item
  10. Dyskinesia 1 item
  11. Friedreich's Ataxia 1 item
  12. Glioblastoma 1 item
  13. Glioma 1 item
  14. Hepatocellular Carcinoma 1 item
  15. Leukemia 2item
  16. Lung Cancer 3item
  17. Lymphoma 2item
  18. Melanoma 2item
  19. Mixed Lineage Leukemia 1 item
  20. Multiple Myeloma 3item
  21. Myelofibrosis 1 item
  22. Non-small Cell Lung Cancer 2item
  23. Ovarian Cancer 2item
  24. Prostate Cancer 8item
  25. Renal Cell Carcinoma 1 item
  26. Rheumatoid Arthritis 1 item